• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝虫病相关急性腺淋巴管炎的初步研究,特别涉及诱发因素和治疗方式。

A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities.

作者信息

Shenoy R K, Sandhya K, Suma T K, Kumaraswami V

机构信息

Department of Medicine, TD Medical College Hospital, Alleppey, Kerala, India.

出版信息

Southeast Asian J Trop Med Public Health. 1995 Jun;26(2):301-5.

PMID:8629065
Abstract

Episodic adenolymphangitis (ADL) is one of the important clinical manifestations of lymphatic filariasis. Recurrent ADLs contribute to the progress of the disease and also have important socioeconomic implications since they cause significant loss of man days. The present study was conducted in order to identify the precipitating factors responsible for ADL attacks and also to examine the different modalities of treatment. Sixty-five individuals with filariasis related ADL attacks, who are residents of Alleppey district (endemic for Brugia malayi) were studied. All efforts were taken to identify the precipitating factors for ADLs in these individuals. They were hospitalized for a period of five days or more. All of them received symptomatic antipyretic/antiinflammatory therapy and topical antibiotic/antifungal treatment of the affected limbs. They were then randomly allocated to one of the following four regimens: group I - symptomatic alone; group II - symptomatic plus antibiotics; group III - symptomatic followed by diethylcarbamazine citrate (DEC) and group IV - symptomatic plus antibiotic followed by DEC. Patients in groups III and IV received DEC every three months up to one year. There was a significant relationship between the number of ADL attacks and the grade of edema. Presence of focus of infection in the affected limb could be identified in 28 of the 65 patients. In the majority of patients (48) response to treatment was rapid (resolution in less than five days). Neither antibiotics nor DEC (given at intervals of three months) appeared to alter the frequency of ADL attacks. On the otherhand simple hygienic measures combined with good foot care and local antibiotic/antifungal cream application (where required), were effective in reducing the number of ADL attacks.

摘要

发作性腺淋巴管炎(ADL)是淋巴丝虫病的重要临床表现之一。复发性ADL会促使疾病进展,还具有重要的社会经济影响,因为它们会导致大量工作日的损失。本研究旨在确定导致ADL发作的诱发因素,并研究不同的治疗方式。对65名居住在阿拉普扎区(马来布鲁线虫流行区)、患有与丝虫病相关的ADL发作的个体进行了研究。尽一切努力确定这些个体中ADL的诱发因素。他们住院观察了五天或更长时间。所有人都接受了对症的退热/抗炎治疗以及对患肢进行局部抗生素/抗真菌治疗。然后将他们随机分配到以下四种治疗方案之一:第一组——仅对症治疗;第二组——对症治疗加抗生素;第三组——对症治疗后服用枸橼酸乙胺嗪(DEC);第四组——对症治疗加抗生素后服用DEC。第三组和第四组的患者每三个月服用一次DEC,持续一年。ADL发作次数与水肿程度之间存在显著关系。65名患者中有28名在患肢发现了感染灶。大多数患者(48名)对治疗反应迅速(不到五天症状消退)。抗生素和DEC(每三个月服用一次)似乎都没有改变ADL发作的频率。另一方面,简单的卫生措施加上良好的足部护理以及在必要时局部涂抹抗生素/抗真菌乳膏,可有效减少ADL发作的次数。

相似文献

1
A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities.丝虫病相关急性腺淋巴管炎的初步研究,特别涉及诱发因素和治疗方式。
Southeast Asian J Trop Med Public Health. 1995 Jun;26(2):301-5.
2
The efficacies of affected-limb care with penicillin diethylcarbamazine, the combination of both drugs or antibiotic ointment, in the prevention of acute adenolymphangitis during bancroftian filariasis.使用青霉素双乙酰胺嗪、两种药物联合使用或抗生素软膏进行患肢护理,在预防班氏丝虫病期间急性腺淋巴管炎方面的疗效。
Ann Trop Med Parasitol. 2004 Oct;98(7):685-96. doi: 10.1179/000349804225021451.
3
A randomized clinical trial to compare the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lymphoedema.一项随机临床试验,比较三种治疗方案联合足部护理在丝虫性淋巴水肿发病管理中的疗效。
Trop Med Int Health. 2005 Jul;10(7):698-705. doi: 10.1111/j.1365-3156.2005.01442.x.
4
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.一项关于口服青霉素、乙胺嗪或对患肢进行局部治疗预防布鲁氏丝虫病所致淋巴水肿急性腺淋巴管炎疗效的双盲、安慰剂对照研究。
Ann Trop Med Parasitol. 1999 Jun;93(4):367-77. doi: 10.1080/00034989958366.
5
[Studies on the recurrent attacks of acute adenolymphangitis due to Malayan filariasis].[马来丝虫病所致急性腺淋巴管炎复发发作的研究]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000;18(2):79-83.
6
Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.布氏丝虫病急性腺淋巴管炎的预防:伊维菌素与乙胺嗪分别联合局部治疗患侧肢体的疗效比较
Ann Trop Med Parasitol. 1998 Jul;92(5):587-94. doi: 10.1080/00034989859285.
7
Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis.抗链球菌溶血素O滴度的测定作为链球菌感染引发布鲁氏丝虫病急性腺淋巴管炎的一项指标。
Southeast Asian J Trop Med Public Health. 1997 Dec;28(4):826-30.
8
Rapid community identification, pain and distress associated with lymphoedema and adenolymphangitis due to lymphatic filariasis in resource-limited communities of North-eastern Nigeria.在尼日利亚东北部资源有限的社区中,快速识别与淋巴水肿和丝虫性淋巴结炎相关的社区、疼痛和痛苦。
Acta Trop. 2011 Sep;120 Suppl 1:S62-8. doi: 10.1016/j.actatropica.2011.03.008. Epub 2011 Apr 4.
9
Changes in complement C3 levels following treatment of patients with Brugia malayi infection.感染马来布鲁线虫病患者接受治疗后补体C3水平的变化。
Southeast Asian J Trop Med Public Health. 1989 Jun;20(2):183-7.
10
Episodic dermatolymphangioadenitis (DLA) in patients with lymphedema of the lower extremities before and after administration of benzathine penicillin: a preliminary study.下肢淋巴水肿患者在注射苄星青霉素前后的发作性皮肤淋巴管腺炎(DLA):一项初步研究。
Lymphology. 1996 Sep;29(3):126-31.

引用本文的文献

1
Three decades of research in lymphatic filariasis-lessons learned.淋巴丝虫病三十年研究——经验教训
Trop Parasitol. 2024 Jul-Dec;14(2):65-70. doi: 10.4103/tp.tp_22_24. Epub 2024 Sep 3.
2
Managing Lymphedema Induced by Lymphatic Filariasis: Implementing and Improving Care at the Individual and Programmatic Levels.管理淋巴丝虫病引起的淋巴水肿:在个体和项目层面实施并改善护理。
Am J Trop Med Hyg. 2024 Jul 30;111(4_Suppl):3-21. doi: 10.4269/ajtmh.23-0905. Print 2024 Oct 1.
3
Phenotypical characterization, and antibiotics susceptibility patterns of skin bacteria found in podoconiosis patients in the North West Region of Cameroon.
喀麦隆西北部象皮病患者皮肤细菌的表型特征及抗生素药敏模式。
BMC Microbiol. 2023 Jul 17;23(1):189. doi: 10.1186/s12866-023-02923-9.
4
Stage-Dependent Increase of Systemic Immune Activation and CCR5CD4 T Cells in Filarial Driven Lymphedema in Ghana and Tanzania.加纳和坦桑尼亚丝虫性淋巴水肿中全身免疫激活和CCR5 CD4 T细胞的阶段依赖性增加
Pathogens. 2023 Jun 7;12(6):809. doi: 10.3390/pathogens12060809.
5
Evaluating the availability and quality of services for lymphatic filariasis morbidity in Ghana.评估加纳淋巴丝虫病发病率服务的可及性和质量。
PLoS Negl Trop Dis. 2023 Jun 12;17(6):e0010805. doi: 10.1371/journal.pntd.0010805. eCollection 2023 Jun.
6
Filarial Lymphedema Patients Are Characterized by Exhausted CD4 T Cells.丝虫性淋巴水肿患者的特征是耗尽的 CD4 T 细胞。
Front Cell Infect Microbiol. 2022 Jan 6;11:767306. doi: 10.3389/fcimb.2021.767306. eCollection 2021.
7
Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).为全球消灭淋巴丝虫病规划奠定基础:前 125 年(1875-2000 年)。
Int Health. 2020 Dec 22;13(Suppl 1):S3-S9. doi: 10.1093/inthealth/ihaa061.
8
Quantifying the socio-economic impact of leg lymphoedema on patient caregivers in a lymphatic filariasis and podoconiosis co-endemic district of Ethiopia.量化埃塞俄比亚淋巴丝虫病和 Podoconiosis 共疫区腿部淋巴水肿对患者照顾者的社会经济影响。
PLoS Negl Trop Dis. 2020 Mar 3;14(3):e0008058. doi: 10.1371/journal.pntd.0008058. eCollection 2020 Mar.
9
Lymphatic Filariasis in India : Problems, Challenges and New Initiatives.印度的淋巴丝虫病:问题、挑战与新举措
Med J Armed Forces India. 2006 Oct;62(4):359-62. doi: 10.1016/S0377-1237(06)80109-7. Epub 2011 Jul 21.
10
Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.印度奥里萨邦基于社区的淋巴丝虫病淋巴水肿管理项目的经济成本与效益
Am J Trop Med Hyg. 2016 Oct 5;95(4):877-884. doi: 10.4269/ajtmh.16-0286. Epub 2016 Aug 29.